Skip to content
★ Sign in to follow
Total declarations
16
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€1.1M

Latest filing published 03 Sept 2009 for LiveRamp Holdings, Inc., €32k.

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

No signal scores available.

Mary L. Good: trading record in brief

Mary L. Good has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Biogen Inc. and LiveRamp Holdings, Inc. In total, 16 filings cover trades dated from 24 May 2004 to 1 September 2009.

Every open-market trade on record is a sale: 6 sales worth €1.1M. The rest of the record consists of 4 option exercises.

The record was last updated on 3 September 2009 with a transaction (€32k) in LiveRamp Holdings, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Mary L. Good

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ●
    DirectorExecutivesLiveRamp Holdings, Inc.
    45,001 USD0SEC
    5,045 shares@ US$8.92Common Stock, $.10 Par ValueSEC:0000733269-09-000056:0
  • ●
    DirectorExecutivesLiveRamp Holdings, Inc.
    50,001 USD0SEC
    3,592 shares@ US$13.92Common Stock, $.10 Par ValueSEC:0000733269-08-000039:0
  • ◇
    DirectorExecutivesBiogen Inc.
    0SEC
    1,250 sharesCommon StockSEC:0001209191-07-033783:0
  • ●
    DirectorExecutivesLiveRamp Holdings, Inc.
    50,007 USD0SEC
    2,178 shares@ US$22.96Common Stock, $.10 Par ValueSEC:0001226292-07-000001:0
  • ◇
    DirectorExecutivesBiogen Inc.
    137,560 USD0SEC
    9,500 shares@ US$14.48Common StockSEC:0001209191-06-058370:0
  • ▼
    DirectorExecutivesBiogen Inc.
    582,350 USD0SEC
    9,500 shares@ US$61.30Common StockSEC:0001209191-06-058370:1
  • ◇
    DirectorExecutivesBiogen Inc.
    72,400 USD0SEC
    5,000 shares@ US$14.48Common StockSEC:0001209191-06-058370:2
  • ▼
    DirectorExecutivesBiogen Inc.
    315,200 USD0SEC
    5,000 shares@ US$63.04Common StockSEC:0001209191-06-058370:3
  • ◇
    DirectorExecutivesBiogen Inc.
    144,800 USD0SEC
    10,000 shares@ US$14.48Common StockSEC:0001209191-06-026701:0
  • ▼
    DirectorExecutivesBiogen Inc.
    112,775 USD0SEC
    2,500 shares@ US$45.11Common StockSEC:0001209191-06-026701:1
  • ▼
    DirectorExecutivesBiogen Inc.
    113,025 USD0SEC
    2,500 shares@ US$45.21Common StockSEC:0001209191-06-026701:2
  • ▼
    DirectorExecutivesBiogen Inc.
    158,725 USD0SEC
    3,500 shares@ US$45.35Common StockSEC:0001209191-06-026701:4
  • ●
    DirectorExecutivesLiveRamp Holdings, Inc.
    35,027 USD0SEC
    1,445 shares@ US$24.24Common Stock, $.10 Par ValueSEC:0001226292-06-000003:0
  • ●
    DirectorExecutivesLiveRamp Holdings, Inc.
    27,755 USD0SEC
    1,145 shares@ US$24.24Common Stock, $.10 Par ValueSEC:0001226292-06-000001:0

14 of 14 declarations